These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36627465)

  • 1. Risk and Prophylactic Management of Gallstone Disease in Bariatric Surgery: a Systematic Review and A Bayesian meta-analysis.
    Amorim-Cruz F; Santos-Sousa H; Ribeiro M; Nogueiro J; Pereira A; Resende F; Costa-Pinho A; Preto J; Lima-da-Costa E; Sousa-Pinto B;
    J Gastrointest Surg; 2023 Feb; 27(2):433-448. PubMed ID: 36627465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Safety and Necessity of Concomitant Cholecystectomy During Bariatric Surgery in Patients with Obesity: a Systematic Review and Meta-analysis.
    Xia C; Wang M; Lv H; Li M; Jiang C; Liu Z; Yang Q
    Obes Surg; 2021 Dec; 31(12):5418-5426. PubMed ID: 34564789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic Cholelithiasis and Bariatric Surgery: a Comprehensive Long-Term Analysis of the Risks of Biliary Disease in Patients Undergoing Primary Roux-en-Y Gastric Bypass.
    Cunningham RM; Jones KT; Kuhn JE; Dove JT; Horsley RD; Daouadi M; Gabrielsen JD; Petrick AT; Parker DM
    Obes Surg; 2021 Mar; 31(3):1249-1255. PubMed ID: 33230759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience.
    Sneineh MA; Harel L; Elnasasra A; Razin H; Rotmensh A; Moscovici S; Kais H; Shirin H
    Obes Surg; 2020 Mar; 30(3):846-850. PubMed ID: 31901127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.
    Pineda O; Maydón HG; Amado M; Sepúlveda EM; Guilbert L; Espinosa O; Zerrweck C
    Obes Surg; 2017 Jan; 27(1):148-153. PubMed ID: 27324135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3-Year MBSAQIP propensity-matched analysis of Roux-en-Y gastric bypass with concomitant cholecystectomy: Is the robotic or laparoscopic approach preferred?
    Falvo AM; Vacharathit V; Dove J; Fluck M; Daouadi M; Gabrielsen J; Horsley R; Petrick A; Parker DM
    Surg Endosc; 2021 Aug; 35(8):4712-4718. PubMed ID: 32959181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystectomy in Patients Submitted to Bariatric Procedure: A Systematic Review and Meta-analysis.
    Tustumi F; Bernardo WM; Santo MA; Cecconello I
    Obes Surg; 2018 Oct; 28(10):3312-3320. PubMed ID: 30097898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
    Mulliri A; Menahem B; Alves A; Dupont B
    J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Management of Cholelithiasis in Bariatric Surgery Patients: a Single-Center Experience.
    Petrola Chacón CG; Vilallonga R; González López Ó; García Ruiz de Gordejuela A; Beisani M; Caubet Busquet E; Fort JM; Armengol Carrasco M
    Obes Surg; 2022 Mar; 32(3):704-711. PubMed ID: 34981326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Cholecystectomy for Asymptomatic Gallstones in Bariatric Surgery-Safety Profile and Feasibility in a Large Tertiary Referral Bariatric Center.
    Allatif REA; Mannaerts GHH; Al Afari HST; Hammo AN; Al Blooshi MS; Bekdache OA; Alawadhi O; Isied SH; Hamid S; Shikora SA
    Obes Surg; 2022 Feb; 32(2):295-301. PubMed ID: 34791618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cholecystectomy in morbidly obese patients after bariatric surgery in Taiwan.
    Huang HH; Hsieh MS; Chen CY
    Obes Res Clin Pract; 2019; 13(2):191-196. PubMed ID: 30665822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
    Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
    Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery.
    Guzmán HM; Sepúlveda M; Rosso N; San Martin A; Guzmán F; Guzmán HC
    Obes Surg; 2019 Jul; 29(7):2110-2114. PubMed ID: 31001756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of gallbladder disease after sleeve gastrectomy in a selected Lebanese population.
    Dakour Aridi H; Sultanem S; Abtar H; Safadi BY; Fawal H; Alami RS
    Surg Obes Relat Dis; 2016 Aug; 12(7):1300-1304. PubMed ID: 27178610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How frequently and when do patients undergo cholecystectomy after bariatric surgery?
    Tsirline VB; Keilani ZM; El Djouzi S; Phillips RC; Kuwada TS; Gersin K; Simms C; Stefanidis D
    Surg Obes Relat Dis; 2014; 10(2):313-21. PubMed ID: 24462305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for de novo cholelithiasis after bariatric surgery.
    Andrés-Imaz A; Martí-Gelonch L; Eizaguirre-Letamendia E; Asensio-Gallego JI; Enríquez-Navascués JM
    Cir Esp (Engl Ed); 2021 Nov; 99(9):648-654. PubMed ID: 34635453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric Surgery Before Spine Surgery is Associated With Fewer Postsurgical Complications: A Systematic Review and Meta-Analysis.
    Gupta S; Tao X; Matur AV; Wu A; Chilakapati SS; Palmisciano P; Conteh FS; Duah HO; Shukla G; Vorster P; Garcia-Vargas J; Kwan D; Adogwa O
    Spine (Phila Pa 1976); 2023 Jul; 48(13):944-949. PubMed ID: 37075380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery.
    Leyva-Alvizo A; Arredondo-Saldaña G; Leal-Isla-Flores V; Romanelli J; Sudan R; Gibbs KE; Petrick A; Soriano IS;
    Surg Obes Relat Dis; 2020 Jan; 16(1):158-164. PubMed ID: 31839526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
    Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
    Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.